You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

inetetamab

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Real-world Study of Inetetamab for First-line Treatment of MBC

Not yet recruiting
  • Breast Cancer
  • Real-world Study
  • Inetetamab
  • (no location specified)
Aug 6, 2023

Breast Cancer Trial in Nanjing (Inetetamab, Pyrotinib, Oral Vinorelbine Tartrate)

Recruiting
  • Breast Cancer
  • Inetetamab
  • +2 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Apr 10, 2023

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line

Recruiting
  • Breast Neoplasms
  • Inetetamab
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Mar 16, 2023

Breast Cancer Trial in Beijing (Inetetamab, Toripalimab, Albumin-Bound Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Inetetamab
  • +2 more
  • Beijing, China
    Cancer Hospital Chinese Academy Of Medical Sciences
Mar 14, 2022

RWS of Inetetamab HER2 Positive Advanced Breast Cancer

Not yet recruiting
  • HER2-positive Advanced Breast Cancer
  • Inetetamab
  • (no location specified)
Jul 14, 2021

Metastatic Breast Cancer Trial (Pyrotinib, Vinorelbine, Inetetamab)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jul 11, 2021

NSCLC Trial in Guangzhou (inetetamab, Pytotinib)

Recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Aug 16, 2021

Breast Tumors Trial in Zhengzhou (Pyrotinib Maleate, Dalpiciclib Isethionate Tablets, Inetetamab)

Recruiting
  • Breast Neoplasms
  • Pyrotinib Maleate
  • +3 more
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jun 1, 2022

Breast Cancer Trial in Beijing (Inetetamab, Rapamycin, Pyrotinib)

Not yet recruiting
  • Breast Cancer
  • Inetetamab
  • +3 more
  • Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Jan 31, 2021

Breast Cancer Trial in Guangzhou (Inetetamab, Pyrotinib, Capecitabine)

Recruiting
  • Breast Cancer
  • Inetetamab
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat Sen Memorial Hospital，Sun Yat sen University
Dec 18, 2020